Fund+ logo

Fund+

Europe, Vlaams-Brabant, Belgium, Leuven

Description

Fund+ invests in companies operating in the diagnostics, therapeutics, medical devices, and life science sectors.

Investor Profile

Fund+ has made 28 investments, with 2 in the past 12 months and 32% as lead.

Stage Focus

  • Series B (46%)
  • Series A (36%)
  • Series C (7%)
  • Series Unknown (7%)
  • Seed (4%)

Country Focus

  • Belgium (46%)
  • United States (18%)
  • Germany (11%)
  • France (11%)
  • Spain (11%)
  • The Netherlands (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Life Science
  • Biopharma
  • Genetics
  • Medical Device
  • Neuroscience
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fund+ frequently co-invest with?

Vives Louvain Technology Fund
Europe, Vlaams-Brabant, Belgium, Louvain-la-neuve
Co-Investments: 4
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 3
V-Bio Ventures
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 5
Capricorn Partners
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 3
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 5
S.R.I.W.
Europe, Liege, Belgium, Liège
Co-Investments: 7
PMV
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 6
SFPI-FPIM
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 6
Ackermans & van Haaren
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 3
QI
Europe, Oost-Vlaanderen, Belgium, Ghent
Co-Investments: 3

Which angels does Fund+ often collaborate with?

KC
North America, United States
Shared Deals: 1
DK
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1
DA
Europe, Liege, Belgium, Liège
Shared Deals: 1
FB
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 2
OV
Europe, Belgium
Shared Deals: 1
JS
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1
RT
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1
PD
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Fund+?

Coave Therapeutics

Paris, Ile-de-France, France

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

BiotechnologyGeneticsLife ScienceNeuroscience
Series AJan 9, 2025
Amount Raised: $32,948,556
Confo Therapeutics

Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.

BiotechnologyHealth CareMedicalTherapeutics
Series BJul 26, 2024
Amount Raised: $65,148,419
Tubulis

Munich, Bayern, Germany

Tubulis is a chemotherapeutic medication developer specializing in cancer and chronic disease treatment.

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics
Series BMar 14, 2024
Amount Raised: $139,300,472
Novadip Biosciences

Mont-saint-guibert, Brabant Wallon, Belgium

Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.

BiotechnologyHealth CareMedicalTherapeutics
Series BNov 3, 2022
Amount Raised: $23,398,518
AstriVax

Heverlee, Vlaams-Brabant, Belgium

AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.

Clinical TrialsMedical
SeedAug 25, 2022
Amount Raised: $29,912,416
etherna immunotherapies

Niel, Antwerpen, Belgium

etherna develops mRNA and lipid nanoparticle solutions.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series BAug 23, 2022
Amount Raised: $38,869,747
Minoryx Therapeutics

Barcelona, Catalonia, Spain

Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.

BiotechnologyGeneticsHealth CareMedicalPharmaceutical
Series CMay 31, 2022
Amount Raised: $54,744,055
Tubulis

Munich, Bayern, Germany

Tubulis is a chemotherapeutic medication developer specializing in cancer and chronic disease treatment.

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics
Series BMay 3, 2022
Amount Raised: $63,152,643
TargED Biopharmaceuticals

Utrecht, Utrecht, The Netherlands

TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series AFeb 19, 2022
Amount Raised: $44,156,009
EyeD Pharma

Liège, Liege, Belgium

EyeD Pharma is a pharmaceutical company dedicated to the development of innovative drug products in ophthalmology.

BiopharmaBiotechnologyPharmaceutical
Series UnknownDec 24, 2021
Amount Raised: $50,951,260